Evidence map›Paper›PMID 24794439›Full record

ArticleCell reports2014

Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression.

Conan Kinsey, Vijaya Balakrishnan, Michael R O'Dell, Jing Li Huang, Laurel Newman, Christa L Whitney-Miller, Aram F Hezel, Hartmut Land

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Conan KinseyDepartment of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Vijaya BalakrishnanDepartment of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Michael R O'DellDepartment of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Jing Li HuangDepartment of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Laurel NewmanDepartment of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Christa L Whitney-MillerDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Aram F HezelDepartment of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA; James P. Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA. Electronic address: aram_hezel@urmc.rochester.edu.
Hartmut LandDepartment of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA; James P. Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA. Electronic address: land@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

Gene Networks Essential to Colon Cancer PhenotypeR01CA138249 · NCI · UNIVERSITY OF ROCHESTER · PI LAND, HARTMUT · 2008 to 2012
$2.6M
Multi step tumorigenesis, control of cell cycle entryR01CA090663 · NCI · UNIVERSITY OF ROCHESTER · PI LAND, HARTMUT · 2001 to 2005
$1.7M
Genetics pathways in intra-hepatic cholangiocarcinomaR01CA172302 · NCI · UNIVERSITY OF ROCHESTER · PI HEZEL, ARAM F. · 2013 to 2017
$1.6M
Cooperation of oncogenic mutations in the control of malignancyR01CA120317 · NCI · UNIVERSITY OF ROCHESTER · PI LAND, HARTMUT · 2007 to 2011
$1.5M
The University of Rochester Clinical and Translational Science InstituteTL1TR000096 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$930k
Genomic Instability and The Roles of P53 and P19arf in Pancreatic CancerK08CA122835 · NCI · UNIVERSITY OF ROCHESTER · PI HEZEL, ARAM F. · 2006 to 2010
$712k
Howard Hughes Medical InstituteNCATS NIH HHS TL1 TR000096NCI NIH HHS CA120317NCI NIH HHS CA122835NCI NIH HHS CA138249NCI NIH HHS CA172302NCI NIH HHS CA90663NCI NIH HHS K08 CA122835NCI NIH HHS R01 CA090663NCI NIH HHS R01 CA120317NCI NIH HHS R01 CA138249NCI NIH HHS R01 CA172302
6 · The paper itself

Abstract

Mutations in p53 and RAS potently cooperate in oncogenic transformation, and correspondingly, these genetic alterations frequently coexist in pancreatic ductal adenocarcinoma (PDA) and other human cancers. Previously, we identified a set of genes synergistically activated by combined RAS and p53 mutations as frequent downstream mediators of tumorigenesis. Here, we show that the synergistically activated gene Plac8 is critical for pancreatic cancer growth. Silencing of Plac8 in cell lines suppresses tumor formation by blocking autophagy, a process essential for maintaining metabolic homeostasis in PDA, and genetic inactivation in an engineered mouse model inhibits PDA progression. We show that Plac8 is a critical regulator of the autophagic machinery, localizing to the lysosomal compartment and facilitating lysosome-autophagosome fusion. Plac8 thus provides a mechanistic link between primary oncogenic mutations and the induction of autophagy, a central mechanism of metabolic reprogramming, during PDA progression.

Indexed as

MutationAnimalsAutophagyCarcinoma, Pancreatic DuctalCell DifferentiationCell Line, TumorDisease ProgressionHeterograftsHumansMiceMice, Inbred NODMice, NudeMice, SCIDPancreatic NeoplasmsPromoter Regions, GeneticProteinsPLAC8 protein, humanPlac8 protein, mouseProteins

Identifiers

PMID24794439
PMCPMC4112575
OpenAlexW1965322287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.